CleanSlate Centers, a Nashville, Tenn.-based leader in outpatient pharmacological treatment for the chronic disease of addiction – primarily opioid and alcohol addiction, secured $25m in a recent financing.
The round was led by HealthQuest Capital, which joined existing controlling investor Granite Growth Health Partners.
The company intends to use the funds to continues to accelerate its growth nationally.
Founded in 2009 and led by Gregory Marotta, President and CEO, CleanSlate is a national leader in outpatient pharmacological treatment for the chronic disease of addiction, currently operating 45 centers across eight states, with another 22 centers slated to open this year, and more than 30,000 patients treated with evidence-based medicine.
The company’s addiction treatment program follows guidelines set by the American Society of Addiction Medicine. Its physician-led centers provide individualized, evidence-based treatment for substance abuse, including pharmacological treatment supported by ancillary counseling.
CleanSlate Centers operates in Arizona, Connecticut, Florida, Indiana, Massachusetts, Pennsylvania, Texas, Wisconsin and Washington, D.C. – with plans to open in Ohio, Kentucky and New Jersey.